Bristol-myers Squibb Company recalls EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pf…
- Recall date
- June 5, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0959-2017
- FDA classification
- Class I
- Brand / firm
- Bristol-myers Squibb Company
- Sold / distributed
- Nationwide in the US
Why it was recalled
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21
Get recall alerts
Free email alert whenever Bristol-myers Squibb Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bristol-myers Squibb Company